# Cedars-Sinai Health Ventures

Cedars-Sinai Health Ventures is a Venture Capital based in Los Angeles, United States.

## Overview

- **Organization type:** Venture Capital
- **Headquarters:** Los Angeles, United States
- **Region:** North America
- **Address:** Los Angeles, CA, United States
- **Founded:** 2022
- **Assets under management:** Undisclosed
- **Website:** cedarssinaihv.com

## Regulatory record

- **Reports private funds:** No

## About

Cedars-Sinai Health Ventures is a healthcare and biomedicine technology company based in Los Angeles, California. Founded in 2022, it collaborates with entrepreneurs to develop healthcare solutions. The company has made 14 investments, including a Series B investment in Amae Health on November 06, 2025.

## Sectors

- Digital Health
- Healthcare Services
- Enterprise Software

## People

- James D. Laur — Managing Director, Cedars-Sinai Health Ventures and Chief Intellectual Property Officer, Cedars-Sinai
- Maureen Klewicki — Partner and Head of Investing, Cedars-Sinai Health Ventures
- Darren Dworkin — Founder, former CIO of Cedars-Sinai

## Questions

### Who runs investment decisions at Cedars-Sinai Health Ventures?

James D. Laur, Managing Director of the venture arm and Chief Intellectual Property Officer at Cedars-Sinai, oversees strategy and deal execution. Maureen Klewicki serves as Partner and Head of Investing, running day-to-day investment activities. Both report through the health system's innovation and IP infrastructure, keeping investment decisions aligned with clinical and operational priorities.

### How does the firm source deal flow?

Deal flow originates primarily from Cedars-Sinai's own physicians, researchers, and clinical departments who identify tools they want to use inside the health system. The venture team also evaluates companies through the system's technology-scouting networks, accelerator programming, and convenings like the LSI Emerging Medtech Summit. This internal-referral model means most portfolio companies enter the pipeline because a practicing clinician or IT leader has already flagged the need.

### Does the firm invest in fund commitments or only direct deals?

Public record points almost exclusively to direct investments into healthcare companies, often at early to growth stages. There is no disclosed activity around fund-of-funds commitments or LP stakes in external venture funds. The firm's model favors directing capital into companies where Cedars-Sinai can serve as a clinical partner, first customer, or validation site — something indirect fund commitments generally do not permit.

### What is the relationship between the venture arm and Cedars-Sinai Medical Center?

Cedars-Sinai Health Ventures is a wholly owned and integrated division of Cedars-Sinai Medical Center, not a separately capitalized external entity. The venture arm's managing director, James Laur, also serves as the medical center's Chief Intellectual Property Officer. This dual role ensures that investment strategy, technology transfer, and clinical innovation stay bound together under the same organizational roof.

### What is the firm's known posture on co-investments alongside external GPs?

The firm has not publicly outlined a formal co-investment program, but its participation in networks like LSI Emerging Medtech Summit and MedtechWOMEN signals openness to syndicate with other healthcare-focused investors. Given the medical center's role as a clinical partner, co-investors often gain indirect access to Cedars-Sinai's validation infrastructure, making the venture arm a sought-after syndicate partner for medtech and digital health deals.

## Related profiles

- [Cedar Capital Group](https://altss.com/profile/cedar-capital-group)
- [Cedrus Investments](https://altss.com/profile/cedrus-investments)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/cedars-sinai-health-ventures

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology